Advertisement
Screener

Alpha Cognition Inc. (ACOG) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Alpha Cognition Inc. Cash Flow Breakdown

Cash flow breakdown shows where Alpha Cognition Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $20.38M went out.
  • Fiscal year ended 2025-12-31: from investing, $293.49K went out.
  • Fiscal year ended 2025-12-31: from financing, $38.21M came in.
  • Fiscal year ended 2025-12-31: change in cash, $17.54M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$20.38M-$293.49K$364.61K$37.85M*$17.54M
2024-12-31-$7.76M-$26.70K$3.73M$51.12M*$47.07M
2023-12-31-$8.80M$9.22M-$993.57K*-$589.12K

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$6.86M*-$6.01M*$0.00*
2026-03-31-$11.80M-$1.32K$800.00-$11.80M
2025-12-31-$6.91M*-$147.52K*$1.00*$37.70M*
2025-09-30-$5.29M*-$74.38K*$1.36M*
2025-06-30-$6.14M*-$8.31K*
2025-03-31-$2.04M-$63.27K-$834.30K*-$2.94M
2024-12-31-$2.30M*$0.00*$47.12M*
2024-09-30-$1.58M*$0.00*$4.16M*
2024-06-30-$1.40M*$0.00*
2024-03-31-$2.47M$3.73M$928.49K
2023-12-31-$2.03M*$3.37M*-$755.84K*
2023-09-30-$1.60M*$1.35M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Acumen Pharmaceuticals, Inc. (ABOS)United States$0.162B-1.83
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Alector, Inc. (ALEC)United States$0.213B-1.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37